Categories AlphaGraphs, Cannabis, Earnings
Infographic: Highlights of Aurora Cannabis’ (ACB) Q1 2021 earnings report
Aurora Cannabis, Inc. (NYSE: ACB) reported a loss for the first quarter of 2021, continuing the recent trend. However, the bottom-line performance improved from the previous quarter and the company’s stock gained on Monday morning, following the announcement.
The Canada-based medical marijuana company said its loss from continuing operations narrowed to C$107.2 million in the September quarter from C$1.85 billion in the fourth quarter of 2020. The improvement reflects stable revenue performance, which remained broadly unchanged at C$68 million sequentially.
Read management/analysts’ comments on Aurora’s Q1 results
Shares of Aurora Cannabis closed the last trading session higher in the New York Stock Exchange and continued to gain during Monday’s pre-market session.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more efficiently. The company’s digital platform helps optimize drug procurement and
AMAT Stock: Is now the right time to invest in Applied Materials?
It is estimated that the size of the global chip manufacturing equipment market would nearly double from the current levels to about $142 billion in the next eight years. Applied
Here’s a look at Take-Two Interactive Software’s (TTWO) expectations for the coming year
Shares of Take-Two Interactive Software (NASDAQ: TTWO) were down over 2% on Friday. The stock has dropped 32% year-to-date and 35% over the past 12 months. Earlier this week, the
